Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study.
| Image |  |
|---|---|
| Description | scientific article published on 12 March 2018 |
| Author/s |
author: John M Mariadason |
| Publication date | March 12, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |